AI is helping healthcare teams move faster. Providers use it to draft notes, billing teams use it to support appeals, and administrative staff use it to create patient communications. But when staff use unapproved AI tools without IT, compliance, or leadership oversight, sensitive information can be exposed.
This unchecked use is known as shadow AI. In healthcare practices, it can appear in everyday workflows such as clinical documentation, billing appeals, transcription, note summarization, patient outreach, and internal operations. For multi-location practices, the risk can spread quickly as different offices and departments adopt different tools without a consistent approval process.
The challenge is not to stop AI. The challenge is to govern it. Healthcare practices need to know where AI is being used, what data may be involved, and which controls are needed to reduce privacy, compliance, and security risk.
What Shadow AI looks like in healthcare.
Shadow AI refers to AI-powered tools used without formal review or approval. These may include public chatbots, browser extensions, transcription apps, note summarizers, embedded AI features, AI writing assistants, and other consumer or unmanaged AI platforms.
The intent is usually efficiency. The risk is that these tools may not be approved to handle PHI or other sensitive practice data.
Unapproved AI use can create PHI exposure, patient communication leakage, billing or claims data exposure, vendor and contractual risk, HIPAA or privacy compliance concerns, limited auditability, and inconsistent AI use across locations or departments.
Healthcare remains one of the most expensive industries for data breaches, and shadow AI can add a new unmanaged path for sensitive data to leave approved systems.
How Shadow AI puts patient data at risk.
Shadow AI often appears where visibility is weakest: personal browsers, unmanaged tools, browser extensions, AI plug-ins, transcription apps, or public AI platforms.
Sensitive data may be exposed when staff copy clinical notes into AI tools, use AI to draft visit summaries or care instructions, upload recordings to transcription apps, use browser extensions inside EHR, billing, or messaging systems, generate billing appeals or payer responses, or rewrite patient communications using public AI tools.
The risk is not limited to the prompt itself. Key risk drivers include vendor data retention or logging, lack of a required Business Associate Agreement, unclear data-use or training policies, browser extensions accessing sensitive content, limited visibility into who used AI and why, and sensitive prompts being processed outside approved systems.
A Business Associate Agreement, or BAA, is required under HIPAA when a vendor acts as a business associate and handles PHI on behalf of a covered entity. Without a required BAA, sharing PHI with a vendor may create compliance, notification, and contractual risk.
Step 1: Find where AI is already being used.
Healthcare practices need to identify where AI may already be in use and which workflows are most likely to involve PHI or sensitive business data.
Discovery may include reviewing:
- Network, endpoint, SaaS, and browser activity where available
- Browser extensions, plug-ins, transcription tools, and summarization tools
- Staff workflows and informal AI use
- Existing AI policies and approval processes
High-risk workflows include clinical notes, billing appeals, payer responses, patient communications, transcription, and internal business reporting.
A Shadow AI Risk Assessment can help practices identify where AI may be in use, where sensitive data could be exposed, and what governance, policy, training, or technical controls may be needed.
Step 2: Prioritize the highest-risk data.
Not every AI use case carries the same level of risk. A general marketing draft is different from a full clinical note, billing record, or patient message.
Practices should prioritize workflows where PHI or regulated data could enter unmanaged AI tools. High-risk data may include patient identifiers, clinical notes, full medical records, billing records, insurance information, appeal letters, patient communications, and internal financial or operational data.
Step 3: Define approved AI use.
Blocking all AI may drive staff toward unapproved tools. A better approach is to define what AI use is allowed, which tools are approved, and what data may or may not be entered.
An approved AI framework should define:
- Approved and prohibited tools
- Approved and prohibited use cases
- Whether PHI may be used
- BAA requirements
- Vendor data retention terms
- Logging and auditability expectations
- Access controls
- Review requirements for new tools
Any tool that has not been reviewed for healthcare use should be prohibited from handling PHI.
Step 4: Implement practical technical controls.
Technical controls should reduce the chance that PHI or sensitive practice data enters unapproved AI tools.
Useful controls may include DLP or sensitive-data detection, AI-specific prompt monitoring, browser extension controls, role-based access control, SaaS security or CASB controls where available, endpoint and identity controls, centralized logging, Managed SIEM or MDR, and vendor review and BAA processes.
These controls support a Zero Trust approach: verify access, limit exposure, and improve auditability.
Step 5: Provide governed AI alternatives.
If staff see value in AI but have no approved option, they may use personal accounts or public tools. Practices should provide safe, governed alternatives for common workflows.
Use Case | Safer Approach | Common Shadow AI Risk |
Clinical documentation | Approved AI workflow | Public chatbot used for visit notes |
Transcription | Reviewed transcription platform | Generic speech-to-text app |
Billing appeals | Governed drafting tool | Claims data entered into public AI |
Patient communications | Approved messaging workflow | Patient messages drafted in unmanaged AI |
Internal reporting | Governed analytics workspace | Sensitive reports uploaded to public tools |
Step 6: Train staff on safe AI use.
AI governance only works if staff understand it. Training should be role-specific and practical.
Providers may need guidance on clinical notes and care instructions. Billing teams may need examples involving appeals and payer responses. Administrative teams may need rules for patient communications, FAQs, reminders, and outreach.
A strong training program should include real-world examples of AI risk, clear dos and don’ts, approved tool guidance, role-based scenarios, a process for asking whether a tool is approved, and reporting channels for risky AI use.
Magna5’s User Awareness Training services can support these efforts with managed training, phishing simulations, micro-training, adaptive coaching, role-based tracks, and audit-ready reporting.
Step 7: Build auditability and response plans.
Shadow AI should be part of the broader incident response plan. If a possible AI-related exposure occurs, the practice should know how to investigate and respond.
Approved AI systems should provide appropriate auditability, including user activity, access, usage patterns, administrative actions, and, where supported, interaction-level logging.
If a suspected exposure occurs, response steps may include:
- Identify the tool or workflow involved
- Determine what data may have been entered
- Identify users and timing
- Review vendor approval and BAA status
- Notify internal compliance, legal, IT, and leadership teams
- Preserve logs and evidence where available
- Determine whether notification obligations apply
- Update controls, policies, and training
When to start with a Shadow AI Risk Assessment.
For many healthcare practices, the first step is not buying another tool. It is understanding where AI is already being used and where sensitive data may be at risk.
A Shadow AI Risk Assessment helps answer practical questions: which AI tools may already be in use, which workflows involve PHI or sensitive business data, whether browser extensions or embedded AI features are creating risk, whether AI vendors have been reviewed for privacy and BAA considerations, and whether employees understand what they can and cannot enter into AI tools.
Magna5’s Shadow AI Risk Assessment helps healthcare practices gain visibility, reduce exposure, and create a safer framework for responsible AI use.
FAQs About Shadow AI in healthcare.
Q: What is shadow AI in healthcare?
A: Shadow AI is the use of AI tools by staff without formal approval or oversight. In healthcare, this may include public chatbots, browser extensions, transcription tools, note summarizers, or embedded AI features used for clinical notes, billing appeals, patient communications, or internal practice data.
Q: How does shadow AI put patient data at risk?
A: Shadow AI can put patient data at risk when PHI or sensitive information is entered into tools that have not been approved for healthcare use. Depending on the tool and vendor terms, prompts or uploaded data may be stored, logged, reused, or processed outside approved systems.
Q: What workflows are most exposed?
A: Common high-risk workflows include clinical documentation, visit summaries, referral notes, care instructions, billing appeals, claim justifications, payer responses, transcription, patient communications, appointment reminders, FAQs, and internal reporting.
Q: Why not just ban AI?
A: Banning AI outright can drive staff toward personal accounts and unapproved tools. A better approach is to define approved tools, train staff, monitor risk, and provide governed alternatives.
Q: What controls help reduce shadow AI risk?
A: Controls may include DLP, SaaS security or CASB tools where available, browser extension controls, role-based access, centralized logging, and AI-specific prompt monitoring. Magna5 can support these efforts through Pentaguard AI, Managed SIEM/MDR, Insider Threat Monitoring, and vCISO/GRC services.
Q: How can a practice build a sustainable AI governance program?
A: Start with visibility. A Shadow AI Risk Assessment can help identify where AI may already be in use, which workflows create exposure, and where governance gaps exist. From there, practices can define approved tools, update policies, train users, implement safeguards, and monitor risk over time.
Q: What is Magna5’s Shadow AI Risk Assessment?
A: Magna5’s Shadow AI Risk Assessment is a focused review that helps healthcare practices identify where AI may already be in use, where sensitive data could be exposed, and what governance, policy, training, vendor review, or technical controls may be needed to support responsible AI adoption.
